WallStreetZenWallStreetZen

NASDAQ: EPIX
Essa Pharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their EPIX stock forecasts and price targets.

Forecast return on equity

Is EPIX forecast to generate an efficient return?

Company
232.21%
Industry
140.91%
Market
90.47%
EPIX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EPIX forecast to generate an efficient return on assets?

Company
228.45%
Industry
32.45%
EPIX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EPIX earnings per share forecast

What is EPIX's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.31
Avg 2 year Forecast
$0.16
Avg 3 year Forecast
$3.03

EPIX revenue forecast

What is EPIX's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$174.4M
Avg 2 year Forecast
$339.9M

EPIX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EPIX$1.67N/AN/A
ZURA$1.20$11.25+837.50%Strong Buy
PYXS$1.20$6.50+441.67%Buy
INO$2.00$9.75+387.50%Buy
IGMS$1.21$1.80+48.76%Hold
View Top Biotech Stocks

Essa Pharma Stock Forecast FAQ

What is EPIX's earnings growth forecast for 2025-2027?

(NASDAQ: EPIX) Essa Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.

Essa Pharma's earnings in 2025 is -$28,495,682.On average, 1 Wall Street analyst forecast EPIX's earnings for 2025 to be -$13,760,451, with the lowest EPIX earnings forecast at -$13,760,451, and the highest EPIX earnings forecast at -$13,760,451. On average, 1 Wall Street analyst forecast EPIX's earnings for 2026 to be $7,102,168, with the lowest EPIX earnings forecast at $7,102,168, and the highest EPIX earnings forecast at $7,102,168.

In 2027, EPIX is forecast to generate $134,497,307 in earnings, with the lowest earnings forecast at $134,497,307 and the highest earnings forecast at $134,497,307.

If you're new to stock investing, here's how to buy Essa Pharma stock.

What is EPIX's revenue growth forecast for 2027-2028?

(NASDAQ: EPIX) Essa Pharma's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.68%.

Essa Pharma's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast EPIX's revenue for 2027 to be $7,740,919,235, with the lowest EPIX revenue forecast at $7,740,919,235, and the highest EPIX revenue forecast at $7,740,919,235.

In 2028, EPIX is forecast to generate $15,085,892,603 in revenue, with the lowest revenue forecast at $15,085,892,603 and the highest revenue forecast at $15,085,892,603.

What is EPIX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: EPIX) forecast ROA is 228.45%, which is higher than the forecast US Biotechnology industry average of 32.45%.

What is EPIX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: EPIX) Essa Pharma's current Earnings Per Share (EPS) is -$0.63. On average, analysts forecast that EPIX's EPS will be -$0.31 for 2025, with the lowest EPS forecast at -$0.31, and the highest EPS forecast at -$0.31. On average, analysts forecast that EPIX's EPS will be $0.16 for 2026, with the lowest EPS forecast at $0.16, and the highest EPS forecast at $0.16. In 2027, EPIX's EPS is forecast to hit $3.03 (min: $3.03, max: $3.03).

What is EPIX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: EPIX) forecast ROE is 232.21%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.